coagulation factor X
آخر تحديث 18 Aug 2020
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
ال F10 gene provides instructions for making a protein called coagulation factor X. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
اختيارات الفيديو لـ Genesمكتبة الفيديو
Normal function
ال F10 gene provides instructions for making a protein called coagulation factor X. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
Coagulation factor X is made primarily by cells in the liver. The protein circulates in the bloodstream in an inactive form until the coagulation system is turned on (activated) by an injury that damages blood vessels. When coagulation factor X is activated, it interacts with other coagulation factors to convert an important coagulation protein called prothrombin to its active form, thrombin. Thrombin then converts a protein called fibrinogen into fibrin, which is the material that forms blood clots.
Conditions referring to this gene or chromosome
Other names
autoprothrombin III
prothrombinase
Prower factor
Stuart factor
Stuart-Prower factor
Related patient information and medicines

Patient information leaflet
هل يمكنني تناول أبيكسابان وريبيلسوس معًا؟
There ... These two medicines work in different ways and do not typically interfere with how the other is absorbed, broken down, or removed from the body. Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Rybelsus is a GLP-1 receptor agonist used for type 2 diabetes that mimics.

Patient information leaflet
هل يمكنني تناول أبيكسابان وبيسوبرولول معًا؟
There is no direct interaction between apixaban and bisoprolol. They work in different ways and do not interfere with how the body processes each other. Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Bisoprolol is a beta-blocker that slows the heart rate and lowers blood.

Patient information leaflet
تسمم الحمل
Complications Most women with pre-eclampsia or HE... The risk of complications increases the more severe the pre-eclampsia becomes. The risk of complications is reduced if pre-eclampsia is diagnosed early and treated. A rare but serious complication هو disseminated intravascular coagulation, which can occur if a woman has had to have many blood.

Patient information leaflet
مريء باريت
Barrett'. It typically affects people between the ages of 50 and 70 years. The coil then emits heat ene... Nearby normal cells then multiply and replace the destroyed abnormal cells. Argon plasma coagulation This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR).

Patient information leaflet
اختبارات تخثر الدم
اختبارات تخثر الدم are used to diagnose and assess bleeding problems and to monitor people who take الوارفارين or other مضاد للتخثر medicines. You may be advised to have blood clotting tests: If you have a suspected bleeding disorder. If you develop a blood clot within a blood vessel for ... If you take مضاد للتخثر دواء Anticoagulants.

Patient information leaflet
تخثر الدم
ال clotting cascade makes the blood solidify into a clot, which sticks to the injured part of the blood vessel. Small particles in the blood, called platelets, also help to form the clot. There are also natural chemicals in the blood which act against the clotting system, to stop the blood clotting too much. Thrombophilia occurs if the normal.
قراءة إضافية ومراجع
- coagulation factor X; MedlinePlus, National Library of Medicine.
- Brown DL, Kouides PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia. 2008 Nov;14(6):1176-82. doi: 10.1111/j.1365-2516.2008.01856.x.
- Girolami A, Scarparo P, Scandellari R, Allemand E. Congenital factor X deficiencies with a defect only or predominantly in the extrinsic or in the intrinsic system: a critical evaluation. Am J Hematol. 2008 Aug;83(8):668-71. doi: 10.1002/ajh.21207.
- Girolami A, Vettore S, Scarparo P, Lombardi AM. Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era. Haemophilia. 2011 Jan;17(1):17-20. doi: 10.1111/j.1365-2516.2010.02328.x.
- Herrmann FH, Auerswald G, Ruiz-Saez A, Navarrete M, Pollmann H, Lopaciuk S, Batorova A, Wulff K; Greifswald Factor X Deficiency Study Group. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia. 2006 Sep;12(5):479-89. doi: 10.1111/j.1365-2516.2006.01303.x.
- Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency. Haematologica. 2008 Jun;93(6):934-8. doi: 10.3324/haematol.12211. Epub 2008 Apr 9.
- Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost. 2009 Jun;35(4):407-15. doi: 10.1055/s-0029-1225763. Epub 2009 Jul 13.
- Uprichard J, Perry DJ. Factor X deficiency. Blood Rev. 2002 Jun;16(2):97-110. doi: 10.1054/blre.2002.0191.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
18 Aug 2020 | أحدث إصدار
1 Jan 2015 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

